We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDP
RNS Number : 7566E
InnovaDerma PLC
10 May 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Innovaderma PLC the underlying issuer of existing shares to which voting rights are attached: (ii) --------------------------------------------------------------- --------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------------ ------------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------ ------------------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------ ------------------------------ An event changing the breakdown of voting rights ------------------------------------------------------------------ ------------------------------ Other (please specify): --------------------------------------------------------- ------- ------------------------------ 3. Full name of person(s) Antonios Camille Zamar subject to the notification obligation: (iii) ----------------------------------------------------------- ------------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) JIM Nominees Limited 78 Mount Ephraim, Tunbridge Wells, Kent, TN4 8BS ----------------------------------------------------------- ------------------------------------- 5. Date of the transaction Date of the transaction 9 and date on May 2017 which the threshold is crossed or Date threshold is crossed reached: (v) : 15 May 2017 ----------------------------------------------------------- ------------------------------------- 6. Date on which issuer 10 May 2017 notified: ----------------------------------------------------------- ------------------------------------- 7. Threshold(s) that is/are From above 3% to below 3% crossed or reached: (vi, vii) ----------------------------------------------------------- ------------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- --------------------------- -------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ------------ ------------- ------------ --------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------- ------------ ------- ------------ -------- --------- Ordinary Shares of Below Below EUR0.1 each 399,082 399,082 3% 3% ------------ ------------- ------------ ------- ------------ -------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------- ------------ --------------------------- --------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) ------------- ------------ ------------- ------------ --------------------- ------------------- Nominal Delta ------------- ------------ ------------- ------------ --------------------- -------- --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------ -------------------------------------------------------- Below 3 % ------------------------------------------ --------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBXGDUGDBBGRG
(END) Dow Jones Newswires
May 10, 2017 09:25 ET (13:25 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions